SCHEMBL674092

SCHEMBL674092

CCCCCNCCC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.59
ALDH1A1 P00352 3/20 0.59
AKR1B1 P15121 1/20 0.58
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
PTPN1 P18031 3/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56
PDE4A P27815 1/20 0.56
PDE3A Q14432 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5595496 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL16147341 0.98 TSHR (0.56) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL6758778 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL19798143 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL20138612 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL8437709 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL7954863 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL2749487 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL148702 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL5969053 0.98 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337008-A1 AGROCHEMICAL COMPOSITION, AGROCHEMICAL FORMULATION, USE OF A DIOXABICYCLOALKANE DERIVATIVE, AND, METHOD FOR THE TREATMENT AND/OR PREVENTION OF DISEASES OR PESTS IN A PLANT OR PLANT SEED Oxiteno S.A. Indústria e Comércio (BR) 2024-03-20 EP claimed
US-20230380418-A1 COMPOSITION, AGROCHEMICAL FORMULATION, METHODS FOR INCREASING WATER AND NUTRIENT AVAILABILITY AND FOR IMPROVING PEST CONTROL IN PLANTS AND SEEDS, AND THE AGROCHEMICAL FORMULATION OXITENO S.A. INDÚSTRIA E COMÉRCIO (BR) 2023-11-30 US claimed
EP-4229027-A1 COMPOSITION, AGROCHEMICAL FORMULATION, METHODS FOR INCREASING WATER AND NUTRIENT AVAILABILITY AND FOR IMPROVING PEST CONTROL IN PLANTS AND SEEDS, AND USES OF THE COMPOSITION AND THE AGROCHEMICAL FORMULATION Oxiteno S.A. Indústria e Comércio (BR) 2023-08-23 EP claimed
WO-2022082285-A1 COMPOSITION, AGROCHEMICAL FORMULATION, METHODS FOR INCREASING WATER AND NUTRIENT AVAILABILITY AND FOR IMPROVING PEST CONTROL IN PLANTS AND SEEDS, AND USES OF THE COMPOSITION AND THE AGROCHEMICAL FORMULATION OXITENO S.A. INDÚSTRIA E COMÉRCIO (BR) 2022-04-28 WO claimed
CN-108430221-B Herbicidal composition 美国陶氏益农公司 2022-04-19 CN claimed
CN-107922336-B Control of aquatic weeds using combinations of halauxifen, florpyrauxifen and other herbicides 美国陶氏益农公司 2021-10-22 CN claimed
CN-111836541-A Agrochemical oil dispersions 蓝宝迪有限公司 2020-10-27 CN claimed
CN-105263329-B Methods and compositions for weed control 孟山都技术公司 2020-09-18 CN claimed
CN-111065266-A Herbicidal composition containing pyridine carboxylic acid or its derivative and glyphosate or glufosinate or its derivative 美国陶氏益农公司 2020-04-24 CN claimed
CN-111050551-A Herbicidal compositions comprising pyridine carboxylic acids or derivatives thereof and PDS and VLCFA inhibitors or derivatives thereof 美国陶氏益农公司 2020-04-21 CN claimed
WO-2014151255-A1 METHODS AND COMPOSITIONS FOR WEED CONTROL MONSANTO TECHNOLOGY LLC (US) 2014-09-25 WO claimed
US-20140274712-A1 METHODS AND COMPOSITIONS FOR WEED CONTROL MONSANTO TECHNOLOGY LLC (US) 2014-09-18 US claimed
WO-2014102065-A1 HERBICIDAL COMPOSITION COMPRISING A CORNEXISTIN BASF SE (DE) 2014-07-03 WO claimed
US-8163672-B2 Mixture of fertilizer granules and bioavailable source of nitrogen, phosphorus and potassium and herbicides THE ANDERSONS, INC. (US) 2012-04-24 US claimed
JP-2010523614-A 2010-07-15 JP claimed
EP-2144919-A2 MULTI STEP SYNTHESIS OF IBANDRONATE F. Hoffmann-Roche AG (CH) 2010-01-20 EP claimed
WO-2009093258-A2 A NEW AND IMPROVED PROCESS FOR THE PREPARATION OF IBANDRONATE SODIUM MONOHYDRATE FLEMING LABORATORIES LIMITED (IN) 2009-07-30 WO claimed
WO-2008125483-A2 MULTI STEP SYNTHESIS OF IBANDRONATE F. HOFFMANN-LA ROCHE AG (CH) 2008-10-23 WO claimed
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome ELAN PHARMACEUTICALS, INC. 2008-07-03 US claimed
US-4387232-A Process for preparing N-acylcarnosine AJINOMOTO COMPANY INCORPORATED (JP) 1983-06-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140274712-A1 METHODS AND COMPOSITIONS FOR WEED CONTROL CYC1, PRDX5, CYCS TSHR 4266/4885ALDH1A1 3206/4885AKR1B1 1906/4885
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome BACE1, APP, BACE2 TSHR 4721/4885ALDH1A1 2178/4885AKR1B1 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.